These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9488222)

  • 1. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
    Maeso R; Rodrigo E; Muñoz-Garcia R; Navarro-Cid J; Ruilope LM; Lahera V; Cachofeiro V
    J Hypertens; 1997 Dec; 15(12 Pt 2):1677-84. PubMed ID: 9488222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
    Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
    Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Li P; Ferrario CM; Brosnihan KB
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):198-205. PubMed ID: 9700980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelium in the endothelin-1-mediated potentiation of the norepinephrine response in the aorta of hypertensive rats.
    Zerrouk A; Champeroux P; Safar M; Brisac AM
    J Hypertens; 1997 Oct; 15(10):1101-11. PubMed ID: 9350584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR.
    Maeso R; Rodrigo E; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    Kidney Int Suppl; 1998 Dec; 68():S30-5. PubMed ID: 9839280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of group B Streptococcus on the responses to U46619, endothelin-1, and noradrenaline in isolated pulmonary and mesenteric arteries of piglets.
    Villamor E; Pérez Vizcaíno F; Tamargo J; Moro M
    Pediatr Res; 1996 Dec; 40(6):827-33. PubMed ID: 8947958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats.
    Pucci ML; Miller KB; Dick LB; Guan H; Lin L; Nasjletti A
    Hypertension; 1994 Jun; 23(6 Pt 1):744-51. PubMed ID: 8206572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.
    Ajayi AA; Ogungbade GO; Hercule HC; Oyekan AO; Mutembei L
    Diabetes Res Clin Pract; 2004 Mar; 63(3):155-69. PubMed ID: 14757287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
    Tripodi F; Stanke-Labesque F; Devillier P; Chavanon O; Sessa C; Bessard G
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):734-40. PubMed ID: 10547091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
    Siddiqui AH; Hussain T
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1722-7. PubMed ID: 17142345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a PPAR-gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats.
    Tugrul I; Dost T; Demir O; Gokalp F; Oz O; Girit N; Birincioglu M
    Cardiovasc J Afr; 2016 May/Jun 23; 27(3):164-169. PubMed ID: 27149161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
    Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats.
    Kauser K; Rubanyi GM
    Hypertension; 1995 Apr; 25(4 Pt 1):517-23. PubMed ID: 7721392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction.
    Asano H; Shimizu K; Muramatsu M; Iwama Y; Toki Y; Miyazaki Y; Okumura K; Hashimoto H; Ito T
    J Hypertens; 1994 Apr; 12(4):383-90. PubMed ID: 8064162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ischemia duration and nitric oxide on coronary vasoconstriction after ischemia-reperfusion.
    García-Villalón AL; Amezquita YM; Monge L; Fernández N; Climent B; Sánchez A; Diéguez G
    Eur J Pharmacol; 2005 Feb; 509(2-3):165-70. PubMed ID: 15733552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
    Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
    Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.